Correlation Between Duopharma Biotech and Press Metal

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Duopharma Biotech and Press Metal at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Duopharma Biotech and Press Metal into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Duopharma Biotech Bhd and Press Metal Bhd, you can compare the effects of market volatilities on Duopharma Biotech and Press Metal and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Duopharma Biotech with a short position of Press Metal. Check out your portfolio center. Please also check ongoing floating volatility patterns of Duopharma Biotech and Press Metal.

Diversification Opportunities for Duopharma Biotech and Press Metal

0.42
  Correlation Coefficient

Very weak diversification

The 3 months correlation between Duopharma and Press is 0.42. Overlapping area represents the amount of risk that can be diversified away by holding Duopharma Biotech Bhd and Press Metal Bhd in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Press Metal Bhd and Duopharma Biotech is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Duopharma Biotech Bhd are associated (or correlated) with Press Metal. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Press Metal Bhd has no effect on the direction of Duopharma Biotech i.e., Duopharma Biotech and Press Metal go up and down completely randomly.

Pair Corralation between Duopharma Biotech and Press Metal

Assuming the 90 days trading horizon Duopharma Biotech Bhd is expected to under-perform the Press Metal. But the stock apears to be less risky and, when comparing its historical volatility, Duopharma Biotech Bhd is 2.09 times less risky than Press Metal. The stock trades about -0.13 of its potential returns per unit of risk. The Press Metal Bhd is currently generating about -0.01 of returns per unit of risk over similar time horizon. If you would invest  468.00  in Press Metal Bhd on September 1, 2024 and sell it today you would lose (4.00) from holding Press Metal Bhd or give up 0.85% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthWeak
Accuracy100.0%
ValuesDaily Returns

Duopharma Biotech Bhd  vs.  Press Metal Bhd

 Performance 
       Timeline  
Duopharma Biotech Bhd 

Risk-Adjusted Performance

1 of 100

 
Weak
 
Strong
Weak
Compared to the overall equity markets, risk-adjusted returns on investments in Duopharma Biotech Bhd are ranked lower than 1 (%) of all global equities and portfolios over the last 90 days. Despite quite persistent basic indicators, Duopharma Biotech is not utilizing all of its potentials. The latest stock price mess, may contribute to short-term losses for the institutional investors.
Press Metal Bhd 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Press Metal Bhd has generated negative risk-adjusted returns adding no value to investors with long positions. Despite quite persistent basic indicators, Press Metal is not utilizing all of its potentials. The latest stock price mess, may contribute to short-term losses for the institutional investors.

Duopharma Biotech and Press Metal Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Duopharma Biotech and Press Metal

The main advantage of trading using opposite Duopharma Biotech and Press Metal positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Duopharma Biotech position performs unexpectedly, Press Metal can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Press Metal will offset losses from the drop in Press Metal's long position.
The idea behind Duopharma Biotech Bhd and Press Metal Bhd pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Price Exposure Probability module to analyze equity upside and downside potential for a given time horizon across multiple markets.

Other Complementary Tools

AI Portfolio Architect
Use AI to generate optimal portfolios and find profitable investment opportunities
Portfolio Diagnostics
Use generated alerts and portfolio events aggregator to diagnose current holdings
Insider Screener
Find insiders across different sectors to evaluate their impact on performance
USA ETFs
Find actively traded Exchange Traded Funds (ETF) in USA
Portfolio Dashboard
Portfolio dashboard that provides centralized access to all your investments